drugset / Trial / NCT01764425

Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects

NCT01764425 ↗

Phase 1 Terminated 32 enrolled Piramal Enterprises Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical trial to study the safety tolerability, pharmacokinetics, food effect and pharmacodynamics of a new compound P7435 in in healthy, overweight and/or obese subjects

Timeline

Start
2012-05
Primary completion
2012-09
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator P7435 Unknown 10 mg Oral
Comparator P7435 Unknown 30 mg Oral
Comparator P7435 Unknown 100 mg Oral
Comparator P7435 Unknown 300 mg Oral
Comparator P7435 Unknown 1000 mg Oral

Indications

No indication recorded.